首页> 美国卫生研究院文献>Springer Open Choice >Screening for sexual dysfunction in women diagnosed with breast cancer: systematic review and recommendations
【2h】

Screening for sexual dysfunction in women diagnosed with breast cancer: systematic review and recommendations

机译:筛查诊断为乳腺癌的女性性功能障碍:系统评价和建议

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Breast cancer patients are at increased risk of sexual dysfunction. Despite this, both patients and practitioners are reluctant to initiate a conversation about sexuality. A sexual dysfunction screening tool would be helpful in clinical practice and research, however, no scale has yet been identified as a “gold standard” for this purpose. The present review aimed at evaluating the scales used in breast cancer research in respect to their psychometric properties and the extent to which they measure the DSM-5/ICD-10 aspects of sexual dysfunction. A comprehensive search of the literature was conducted for the period 1992–2013, yielding 129 studies using 30 different scales measuring sexual functioning, that were evaluated in the present review. Three scales (Arizona Sexual Experience Scale, Female Sexual Functioning Index, and Sexual Problems Scale) were identified as most closely meeting criteria for acceptable psychometric properties and incorporation of the DSM-5/ICD-10 areas of sexual dysfunction. Clinical implications for implementation of these measures are discussed as well as directions for further research.
机译:乳腺癌患者性功能障碍的风险增加。尽管如此,患者和从业者都不愿意发起有关性行为的对话。性功能障碍筛查工具将有助于临床实践和研究,但是,尚未为此目的将量表确定为“黄金标准”。本综述旨在评估乳腺癌研究中所使用的量表,涉及其心理计量学特征以及他们测量性功能障碍方面DSM-5 / ICD-10的程度。在1992年至2013年期间对文献进行了全面搜索,使用30种不同的测量性功能的量表进行了129项研究,本研究对此进行了评估。三种量表(亚利桑那州性经验量表,女性性功能指数和性问题量表)被确定为最接近可以接受的心理计量学特征以及性功能障碍的DSM-5 / ICD-10纳入标准。讨论了实施这些措施的临床意义以及进一步研究的方向。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号